NXL — Nexalin Technology, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1527352 ·
Last close
$3.63
Market Cap
$3.01M
52W High
$50.70
52W Low
$3.50
ADV30
2,170,233
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 12,161 | 8,897 | -2,247,315 | -2,239,170 | 3,004,179 | 1,004,958 | 1,484,756 |
| Mar 2026 | 14,950 | 13,133 | -2,119,902 | -2,096,837 | 3,694,633 | 1,207,895 | 808,364 |
| Dec 2025 | 171,895 | 150,866 | -2,413,167 | -2,376,546 | 4,635,319 | 654,783 | 887,333 |
| Sep 2025 | 18,149 | 14,201 | -2,345,631 | -2,276,311 | 5,125,940 | 590,075 | 357,524 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,244,432
Investing CF
$-96,070
Financing CF
$5,926,368
CapEx
$-152,553
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.49
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-94,964,249
Inventory
$179,489
Receivables
$43,004
ST Investments
$1,500,590
EBIT TTM
$-8,499,558
Pretax Income TTM
$-8,330,681
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$217,155
EBITDA
$-9,080,485
Free Cash Flow
$-2,533,424
Enterprise Value
$2,535,553
Total Cash
$1,004,958
Total Debt
$0
Shares Out
829,399
Trailing EPS
$-13.80
Book Value
$2.07
ROE
-240.3%
ROA
-119.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 301,647 | -8,390,881 | -8,222,181 | 4,635,319 | 887,333 | 3,747,986 | -4,957,658 |
| Dec 2024 | 168,721 | -7,754,646 | -7,607,182 | 4,222,732 | 546,694 | 3,676,038 | -3,944,390 |
| Dec 2023 | 110,748 | -5,696,296 | -4,648,709 | 3,631,916 | 425,281 | 3,206,635 | -3,835,384 |
| Dec 2022 | 1,321,357 | -1,833,031 | -1,697,816 | 7,432,136 | 1,953,449 | 5,478,687 | -2,215,699 |
TTM Snapshot
Revenues TTM
$275,582
NetIncome TTM
$-8,330,681
OpCashFlow TTM
—
Assets (Latest)
$3,694,633
Forward EPS
$-9.30
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMIX | Autonomix Medical, Inc. | $3.02M | $3.11 | — |
| VVOS | Vivos Therapeutics, Inc. | $3.00M | $0.15 | — |
| ADGM | Adagio Medical Holdings, Inc. | $2.89M | $0.13 | — |
| ADMT | ADM TRONICS UNLIMITED, INC. | $3.38M | $0.05 | — |
| DROR | Dror Ortho-Design, Inc. | $3.42M | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
2026-10-08 12:30 · Yahoo
Top Midday Gainers
2026-10-01 18:33 · Yahoo
Nexalin Technology Signs South America Distribution Agreement for Nexalin Sync Commercialization
2026-10-01 14:03 · Yahoo
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
2026-10-01 12:30 · Yahoo
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
2026-09-11 13:00 · Yahoo
Nexalin Technology Announces Reverse Stock Split
2026-08-27 11:25 · Yahoo
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Qu
2026-06-10 13:15 · Yahoo
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life
2026-06-10 13:01 · Yahoo
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
2026-06-04 14:00 · Yahoo
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
2026-05-19 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.